Circulating and tissue-derived isoforms of bone alkaline phosphatase in Paget's disease of bone

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 70, Issue 2, 2010, Pages 128-135

  Magnusson, Per ^a   Davie, Michael W J ^b   Sharp, Christopher A ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

Alkaline phosphatase; Bone formation; Bone markers; Bone turnover; Collagen; Paget's disease

Indexed keywords

ALKALINE PHOSPHATASE; ISOENZYME; PROCOLLAGEN C PROTEINASE;

ADULT; AGED; ARTICLE; BONE RADIOGRAPHY; CANCELLOUS BONE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL BONE; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MALE; OSSIFICATION; PAGET BONE DISEASE; PRIORITY JOURNAL; SYMPTOM;

AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BONE AND BONES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; OSTEITIS DEFORMANS; PEPTIDE FRAGMENTS; PROCOLLAGEN;

EID: 77949806071     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365511003642527     Document Type: Article

References (36)

1. Roodman GD, Windle JJ. Paget disease of bone. J Clin Invest 2005;115:200-208
2. van Staa TP, Selby PL, Leufkens HGM, Lyles K, Sprafka JM, Cooper C. Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res 2002;17:465-471
3. Poor G, Donath J, Fornet B, Cooper C. Epidemiology of Paget's disease in Europe: the prevalence is decreasing. J Bone Miner Res 2006;21:1545-1549
4. Haddaway MJ, Davie MWJ, McCall IW, Howdle S. Effect of age and gender on the number and distribution of sites in Paget's disease of bone. Br J Radiol 2007;80:532-536
5. Shankar S, Hosking DJ. Biochemical assessment of Paget's disease of bone. J Bone Miner Res 2006;21(Suppl. 2): P22-P27.
6. Magnusson P, Lofman O, Larsson L. Determination of alkaline phosphatase isoenzymes in serum by high-performance liquid chromatography with post-column reaction detection. J Chromatogr 1992;576:79-86.
7. Magnusson P, Hager A, Larsson L. Serum osteocalcin and bone and liver alkaline phosphatase isoforms in healthy children and adolescents. Pediatr Res 1995;38:955-961
8. Magnusson P, Degerblad M, Saaf M, Larsson L, Thoren M. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone defi ciency. J Bone Miner Res 1997;12:210-220
9. Magnusson P, Larsson L, Englund G, Larsson B, Strang P, Selin-Sjogren L. Differences of bone alkaline phosphatase isoforms in metastatic bone disease and discrepant effects of clodronate on different skeletal sites indicated by the location of pain. Clin Chem 1998;44:1621-1628
10. Magnusson P, Sharp CA, Magnusson M, Risteli J, Davie MWJ, Larsson L. Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int 2001;60:257-265
11. Millan JL. Mammalian alkaline phosphatase. From biology to applications in medicine and biotechnology. Weinheim, Germany: Wiley-VCH Verlag GmgH & Co. KGaA; 2006.
12. Halling Linder C, Narisawa S, Millan JL, Magnusson P. Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms. Bone 2009;45:987-993
13. Davitz MA, Hereld D, Shak S, Krakow J, Englund PT, Nussenzweig V. A glycan-phosphatidylinositol-specifi c phospholipase D in human serum. Science 1987;238:81-84
14. Blom E, Ali MM, Mortensen B, Huseby N-E. Elimination of alkaline phosphatases from circulation by the galactose receptor. Different isoforms are cleared at various rates. Clin Chim Acta 1998;270:125-137
15. Parfi tt AM, Simon LS, Villanueva AR, Krane SM. Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase. J Bone Miner Res 1987; 2:427-436
16. Whyte MP. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 1994; 15:439-461
17. Dobnig H, Sipos A, Jiang Y, Fahrleitner-Pammer A, Ste- Marie L-G, Gallagher JC, Pavo I, Wang J, Eriksen EF. Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy. J Clin Endocrinol Metab 2005;90:3970-3977
18. Magnusson P, Farley JR. Differences in sialic acid residues among bone alkaline phosphatase isoforms: a physical, biochemical, and immunological characterization. Calcif Tissue Int 2002;71:508-518
19. Magnusson P, Larsson L, Magnusson M, Davie MWJ, Sharp CA. Isoforms of bone alkaline phosphatase: characterization and origin in human trabecular and cortical bone. J Bone Miner Res 1999;14:1926-1933
20. Magnusson P, Sharp CA, Farley JR. Different distributions of human bone alkaline phosphatase isoforms in serum and bone tissue extracts. Clin Chim Acta 2002;325:59-70.
21. Sharp CA, Magnusson P. Isoforms of bone alkaline phosphatase, stem cells, and osteoblast phenotypes. Stem Cells Dev 2008;17:857-858
22. Sharp CA, Davie MWJ, Worsfold M, Risteli L, Risteli J. Discrepant blood concentrations of type I procollagen propeptides in active Paget disease of bone. Clin Chem 1996; 42:1121-1122
23. Whyte MP. Paget's disease of bone. N Engl J Med 2006; 355:593-600.
24. Marshall MJ, Evans SF, Sharp CA, Powell DE, McCarthy HS, Davie MWJ. Increased circulating Dickkopf-1 in Paget's disease of bone. Clin Biochem 2009;42:965-969
25. Gomez Jr B, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff GY, Kung VT. Monoclonal antibody assay for measuring bone-specifi c alkaline phosphatase activity in serum. Clin Chem 1995;41:1560-1566
26. Broyles DL, Nielsen RG, Bussett EM, Lu WD, Mizrahi IA, Nunnelly PA, Ngo TA, Noell J, Christenson RH, Kress BC. Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase. Clin Chem 1998;44:2139-2147
27. Magnusson P, Arlestig L, Paus E, Di Mauro S, Testa MP, Stigbrand T, Farley JsR, Nustad K, Millan JL. Monoclonal antibodies against tissue-nonspecifi c alkaline phosphatase. Report of the ISOBM TD9 workshop. Tumour Biol 2002; 23:228-248
28. Magnusson P, Lofman O, Larsson L. Methodological aspects on separation and reaction conditions of bone and liver alkaline phosphatase isoform analysis by high-performance liquid chromatography. Anal Biochem 1993; 211:156-163
29. Melkko J, Kauppila S, Niemi S, Risteli L, Haukipuro K, Jukkola A, Risteli J. Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem 1996; 42:947-954
30. Brown SJ, Pollintine P, Powell DE, Davie MWJ, Sharp CA. Regional differences in mechanical and material properties of femoral head cancellous bone in health and osteoarthritis. Calcif Tissue Int 2002;71:227-234
31. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-254
32. Panigrahi K, Delmas PD, Singer F, Ryan W, Reiss O, Fisher R, Miller PD, Mizrahi I, Darte C, Kress BC, Christenson RH. Characteristics of a two-site immunoradiometric assay for human skeletal alkaline phosphatase in serum. Clin Chem 1994;40:822-828
33. Swolin-Eide D, Hansson S, Larsson L, Magnusson P. The novel bone alkaline phosphatase B1x isoform in children with kidney disease. Pediatr Nephrol 2006;21:1723-1729
34. Sharp CA, Linder C, Magnusson P. Analysis of human bone alkaline phosphatase isoforms: comparison of isoelectric focusing and ion-exchange high-performance liquid chromatography. Clin Chim Acta 2007;379:105-112
35. Naot D, Bava U, Matthews B, Callon KE, Gamble GD, Black M, Song S, Pitto RP, Cundy T, Cornish J, Reid IR. Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone. J Bone Miner Res 2007;22:298-309.
36. Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res 1993;8:127-132